CClinicalTrials.gg
CompletedNCT05358613Updated Jan 17, 2024

My Choices: Efficacy and Implementation Study

An interventional study of My Choices in Alcohol Use Disorder, Mild and Alcohol Use, Unspecified, sponsored by Université du Québec à Trois-Rivières. Completed at 5 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-17.

Sponsored by Université du Québec à Trois-Rivières · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Oct 2021, registered Apr 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
167
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to assess the efficacy of the My Choices - Alcohol program by comparing alcohol-use of people before and after doing the program to people that did not do the program on the same period of time (3 months).

Read the detailed description

People with an alcohol addiction problem consume an average of 26.3 (sd = 12.4) drinks per week (Cournoyer et al., 2010). To observe a decrease of 25% in this average number of drinks for the group participating in the program " My Choices " immediately compared to the delayed group at 3 months, we need a sample size of 100 participants. This calculation assumes an alpha of 5%, a power of 80% and unbalanced groups due to the randomization method used. Considering an attrition rate of 11.3% at 3 months and 20% at 6 months (Tremblay et al., Submitted), it will be necessary to recruit at least 120 participants to maintain the required number for analyses.

References Cournoyer, L.-G., Simoneau, H., Landry, M., Tremblay, J., \& Patenaude, C. (2010). Évaluation d'implantation du programme Alcochoix+ (FQRSC #2008-TO-120890). F. q. d. r. s. l. s. e. l. culture.

Tremblay, J., Dufour, M., Bertrand, K., Saint-Jacques, M., Ferland, F., Blanchette-Martin, N., Savard, A.-C., Côté, M., Berbiche, D., \& Beaulieu, M. (Submitted). Efficacy of a Randomized Controlled Trial of Integrative Couple Treatment for Pathological Gambling (ICT-PG): 10-Month Follow-Up. Journal of Consulting and Clinical Psychology.

02

Conditions studied

  • Alcohol Use Disorder, Mild
  • Alcohol Use, Unspecified

Keywords

  • Alcohol
  • Treatment
03

In context

Alcoholism

1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.

This study's enrollment of 167 is above the median of 87 across 1,371 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Université du Québec à Trois-Rivières is the lead sponsor of 40 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults with at risk alcohol use (alcohol use over the Canadian low-risk alcohol drinking guidelines, without or with low consequences associated with their alcohol use).

Exclusion criteria

Exclusion Criteria:

  • Score at the DEBA (Assessment and Screening of Assistance needs) indicates a need for specialized treatment.
  • Hospitalization for mental health problems in the last 30 days
  • People with unstable mental health condition
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
167 participants (actual)

Study arms

  • Experimental
    Immediate treatment

    The My Choices program will be offered immediately (maximum 10 working days from their first research interview) to the participants of this group. The treatment will be dispensed as usual, wich means there are no special conditions that need to be respected specifically for the study.

    Behavioral: My Choices

  • Active comparator
    Waiting list

    The My Choices program will be offered 3 months after the first research interview to the participants in this group. The treatment will be dispensed as usual, wich means there are no special conditions that need to be respected specifically for the study.

    Behavioral: My Choices

Interventions

  • BehavioralMy Choices

    The My Choices program is an harm reduction program to modify substance use habits. It is based on the Miller \& Rollnick Motivational interviewing as well as Deci and Ryan's Self-determination theory and Bandura's social learning theory. It is presented as a guide, divided in 6 phases. In every phase, participants will find, in the guide, some auto-observation exercises about their alcohol use habits and other aspects about their quality of life, reflexions and information about alcohol. The participants are also invited to note the number of standard units of alcohol they use on every occasion.

    Also known as: Alcochoix+

06

What researchers measure

Primary outcomes

  1. Change in self-reports of alcohol with the time-line follow-back (TLFB) in the last 90 days

    The timeline follow-Back is a research tool to obtain self-reported quantitatives estimates of alcohol used every day in the last 3 months in term of standard drink. (Sobell \& Sobell) Participants are asked in the first interview (2 weeks within eligibility evaluation) to remember day by day how many standard drinks they have had in the last 90 days.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  2. Change in the Short Alcohol Dependance Data Questionnaire (SADD)

    Short Alcohol Dependence Data questionnaire (SADD) is used to measure the severity of alcohol dependence. It comprises 15 items with a four-point frequency scale (never,sometimes, often, nearly always). A total score between 0 and 45 is obtained by adding the score from each of the items. Scores between 0 - 9 indicates low dependence, scores between 10 - 19 indicates medium dependence and a score of 20 or more indicates high dependence.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  3. Change in the Inventory of consequences associated with alcohol use

    It is a 7-items questionnaire, with a 0-10 (Never to always) scale that measures the consequences of alcohol consumption.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  4. Change in the Severity of dependence scale (SDS)

    The Severity of Dependence Scale (SDS) is a 5-item self-administered questionnaire that provides a score indicating the severity of dependence on drugs with a 4-point scale from 0 (Never) to 3 (Always). Score 0 indicates no dependence, score between 1-2 indicates low dependence, score between 3-5 indicates moderate dependance and score between 6 and 15 indicates a high dependance.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

Secondary outcomes

  1. Satisfaction with Life Domains Scale

    20-items scale to assess the perceived quality of life. Participants can answer with 7 faces emojis (3 degrees of sadness, 3 degrees of happiness and 1 neutral).

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  2. Medical Outcomes Study-Social Support Survey (MOS-SSS)

    8-items scale (Domains tangible and Emotional support), with a 5-point Likert scale ranging from 0 (None) to 4 (All of the time).

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  3. Readiness to change

    12-items scale with a 5 point Likert scale ranging from strongly disagree (-2) to strongly agree (2). This questionnaire assesses the motivation level to change alcohol use habits. The levels used are those of the transtheoretical model of change (Prochaska \& DiClemente). The highest score indicates the stage in which the person is (precontemplation, contemplation or action) from a possibility from -8 to 8.

    Time frame: 2 weeks within eligibility evaluation

  4. Motivations to change

    15-items scale with a 7 point Likert-like scale ranging from 1 (not at all) to 7 (Exactly) to assess the type of motivation that drives the person to modify his/her alcohol use habits. The questionnaire is based on the self-determination theory of Deci \& Ryan. It is possible to assess the coefficient of self-determination by adding up the score of the identified and introjected motivation, and substracting to that score the external and amotivation scores. The higher is the coefficient of self-determination, the more internal is the motivation.

    Time frame: 2 weeks within eligibility evaluation

  5. Generalized Anxiety Disorder (GAD-7)

    Subjects are asked how often, during the last 2 weeks, they were bothered by each symptom. Response options were "not at all," "several days," "more than half the days," and "nearly every day," scored as 0, 1, 2, and 3, respectively (Löwe, Williams, Kroenke, Spitzer, 2006). A score between 0 and 4 means a minimal level of anxiety, between 5 and 9 means a mild level of anxiety, 10 to 14 means a moderate level of anxiety and a score between 15 and 21 means severe anxiety.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  6. World Health Organization Well-Being Index (WHO-5)

    5-items scale with a 6 point Likert-like scale ranging from 0 (At no time) to 5 (All of the time). It is a subjective measure of the positive dimensions of mental health. Total score is between 0 to 100. Higher the score, better the level of well-being. A score under 50 could mean a higher risk of depression.

    Time frame: 2 weeks within eligibility evaluation

  7. Impulsivity assessment with the Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior Scale, short version (UPPS-P short)

    It is a 20-items scale with a 4-point Likert-like scale from 1 (Agree strongly) to 4 (Disagree strongly). The items are representing 5 factors, which are negative and positive Urgency, sensation seeking, premedition (lack of) and perseverance (lack of). Scores are between 4 and 16 for each factor. The higher the score, the more impulsive is the person.

    Time frame: 2 weeks within eligibility evaluation

  8. Attention disorder and hyperactivity disorder (ADHD) assesment

    6-items scale with a 5-point Likert-like scale from Never to Really often. If a person answers often or really often 4 times or more, it means that the person shows symptoms associated with ADHD.

    Time frame: 2 weeks within eligibility evaluation

  9. Patient Health Questionnaire (PHQ-9)

    9-items scale with a 4-point Likert-like scale from 0 (Not at all) to 3 (Nearly every day). The total score is obtained by adding up the answer to every 9 items, ranging from 0 to 27. The score indicates the level of depression severity: 0-4 indicates none or minimal severity, 5-9 indicates a mild severity, 10-14 indicates a moderate severity, 15-19 indicates a moderately severe depression and 20-27 indicates a severe depression.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  10. Work and social adjustment scale (WSAS)

    5-items scale with a 9 point scale from 0 (Not at all) to 8 (very severely). The total score can be obtain by adding up the score of every items. A score above 20 suggests moderately severe or worse impairment. Scores between 10 and 20 are associated with significant functional impairment. Scores below 10 appear to be associated with subclinical populations.

    Time frame: 2 weeks within eligibility evaluation

  11. Perceived Improvement Questionnaire

    23-items scale with a 4 point-scale from ''Worse than before'' to ''Much better than before''. The ratings allow the participants to judge to what degree their life has improved in 23 domains since the last 3 months.

    Time frame: 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  12. Client Satisfaction Questionnaire (CSQ-3)

    3-items scale. The first item can be answered with a 4-point Likert-like scale from ''None of my needs were met'' to ''Almost all of my needs were met''. The second item can be answered with a 4-point Likert-like scale from ''Really satisfied'' to ''Really unsatisfied'' and the third item can be answered with a 4-point Likert-like scale from ''No, definitely not'' to ''Yes, definitely''.

    Time frame: 3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list''

  13. Scale to Assess the Therapeutic Relationship-Client (STAR-C)

    12-items scale, with three domains (positive collaboration, emotional difficulties and positive clinician input), with a 5-point Likert-like scale ranging from 0 (Never) to 4 (Always). Total score can range from 0 to 48. The score can be obtained by adding up the score of every item. The scores from the ''emotional difficulties'' domain must be reversed. The higher the score the better is the therapeutic relationship.

    Time frame: 3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list''

  14. Perception of reaching the goal

    Participants are asked to what extent they reached their goal about their alcohol use on a scale from 0 (Not at all) to 10 (Totally).

    Time frame: 3 months after first interview for the arm ''immediate treatment'' and 6 months after first interview for the group ''waiting list''

  15. Difficulties associated with the alcohol-use

    The participants are asked to what extent their alcohol use has caused them difficulties in the last 12 months, with a scale from 0 (Not at all) to 10 (Extremely).

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  16. Importance of change

    The participants are asked: to what extent is it important for you to change your alcohol use habits, with a scale from 0 (Not at all) to 10 (Extremely).

    Time frame: 2 weeks within eligibility evaluation

  17. Perception of actual alcohol use

    The participants are asked: what do you currently think about your alcohol-use? with a scale from 0 (Not at all) to 10 (Extremely).

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  18. Confidence to reach the alcohol use goal

    The participants are asked: How confident are you of reaching your goals about your alcohol-use? with a scale from 0 (Not at all) to 10 (Extremely).

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

  19. High-risk situations of alcohol use assessment

    Questionnaire to assess the situations in which the person is more at risk to drink and the level of confidence to not drink in this situation. The items are measured with a 0 (Never) to 10 (Always) Likert-like scale.

    Time frame: 2 weeks within eligibility evaluation, 3 and 6 months after first interview (The first admission has been October 28th and the last one is anticipated June 30th)

07

Study locations

5 sites
  • Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean
    Jonquière, Quebec G7X 3A9, Canada
  • Centre Intégré de Santé Services Sociaux de Laval
    Laval, Quebec H7M 3L9, Canada
  • Centre intégré de Santé et de Services Sociaux de Chaudière-Appalaches
    Lévis, Quebec G6V 0M4, Canada
  • Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale
    Québec, G1J 0A4, Canada
  • Université du Québec à Trois-Rivières
    Québec, G1M 3E5, Canada
08

References and documents

Study documents

  • Informed consent form · Apr 8, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05358613
Lead sponsor
Université du Québec à Trois-Rivières
Responsible party
Joël Tremblay (Professor, Université du Québec à Trois-Rivières) — Principal investigator
First posted
May 3, 2022
Start date
Oct 28, 2021
Primary completion
May 14, 2023
Completion
May 14, 2023
Last update
Jan 17, 2024

Study contacts

Joël Tremblay, Ph.D.
principal investigator · Université du Québec à Trois-Rivières

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion